Oncology & Cancer
New drug combination helps kickstart the immune system to fight back against cancer
Scientists from King's College London have found a way to boost the immune system to help it fight back against cancer.
Jan 17, 2018
0
20
Page 2 - News tagged with chemotherapy combination
Oncology & Cancer
The best treatment for laryngeal cancer? This approach helps decide
Even as treatment options for laryngeal cancer seemed to improve, survival rates did not. For the most advanced patients, 50 percent survival was the norm, whether patients had surgery to totally remove the voice box or alternative ...
Feb 2, 2017
0
0
Oncology & Cancer
Niraparib significantly improves outcome of ovarian cancer patients in landmark trial
The PARP inhibitor niraparib significantly improves the outcome of platinum-sensitive recurrent ovarian cancer, according to full data from the ENGOT-OV16/NOVA trial presented for the first time at the ESMO 2016 Congress ...
Oct 8, 2016
0
4
Oncology & Cancer
More chemo drugs don't improve treatment of rare bone cancer
Osteosarcoma patients with tumors that haven't responded well to the standard chemotherapy regimen have unimproved outcomes and more side effects when given two additional drugs, a large international trial has found.
Aug 26, 2016
0
0
Oncology & Cancer
Analytics approach could improve chemo combinations
(HealthDay)—Models based on machine learning and optimization could improve chemotherapy regimens to be tested in phase III clinical trials without altering the toxicity outcomes, according to a study published in the May ...
May 9, 2016
0
1
Oncology & Cancer
Combo treatment may boost survival with advanced prostate cancer
(HealthDay)—Chemotherapy at the start of hormone therapy can extend the lives of men with prostate cancer that has spread beyond the gland, a new study finds.
Aug 6, 2015
0
32
Oncology & Cancer
Study identifies possible new combination chemotherapy for patients with advanced prostate cancer
For more than a decade, oncologists using cytotoxic chemotherapy to treat patients with advanced metastatic castration-resistant prostate cancer (mCRPC) have relied on the sequential use of single agent taxanes such as docetaxel ...
May 31, 2015
0
17
Medications
FDA: Akynzeo approved for chemo-related nausea / vomiting
(HealthDay)—The combination drug Akynzeo (netupitant and palonosetron) has been approved by the U.S. Food and Drug Administration to treat nausea and vomiting among people undergoing chemotherapy, the agency said Friday ...
Oct 11, 2014
0
0
Oncology & Cancer
Unexpected results in cancer drug trial
Research from the University of Southampton has shown a drug, used in combination with chemotherapy to treat advanced colorectal cancer, is not effective in some settings, and indeed may result in more rapid cancer progression.
Apr 8, 2014
0
0
Oncology & Cancer
Doxorubicin alone or with ifosfamide for treating soft tissue sarcoma?
An EORTC study published in The Lancet Oncology does not support administration of intensified doxorubicin and ifosfamide for palliation of advanced soft tissue sarcoma, unless the objective is to shrink the tumor.
Mar 25, 2014
0
0
